![Andreas Harstrick](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Andreas Harstrick
Directeur Technique/Scientifique/R&D chez
AFFIMED N.V.
Profil
Andreas Harstrick is currently the Chief Medical Officer at Affimed NV.
He previously worked as the Director at Lilly Oncology.
From 2008 to 2014, he served as the Senior Vice President-Medical Sciences at ImClone LLC.
He was also the Chief Medical Officer at Molecular Partners AG from 2015 to 2019.
Prior to that, he held the position of SVP-Global Clinical Development Unit Oncology at Merck Serono Ltd. from 1998 to 2008.
Dr. Harstrick's education includes a doctorate degree from the University of Hannover in 1986.
Postes actifs de Andreas Harstrick
| Sociétés | Poste | Début |
|---|---|---|
| AFFIMED N.V. | Directeur Technique/Scientifique/R&D | 01/03/2020 |
Anciens postes connus de Andreas Harstrick
| Sociétés | Poste | Fin |
|---|---|---|
| MOLECULAR PARTNERS AG | Directeur Technique/Scientifique/R&D | 01/09/2019 |
ImClone LLC
 ImClone LLC BiotechnologyHealth Technology Develops novel therapeutic products and blood cell growth factors for the treatment of cancer | Corporate Officer/Principal | 01/01/2014 |
Merck Serono Ltd.
 Merck Serono Ltd. Miscellaneous Commercial ServicesCommercial Services Provides research and development services and manufactures medicinal drugs | Corporate Officer/Principal | 01/01/2008 |
University of Duisburg-Essen
 University of Duisburg-Essen Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Lilly Oncology
 Lilly Oncology Hospital/Nursing ManagementHealth Services Provides cancer treatment services | Directeur/Membre du Conseil | - |
Formation de Andreas Harstrick
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
66
Relations au 1er degré
7
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 7 |
|---|---|
ImClone LLC
ImClone LLC BiotechnologyHealth Technology Develops novel therapeutic products and blood cell growth factors for the treatment of cancer | Health Technology |
Affimed NV
 Affimed NV Pharmaceuticals: MajorHealth Technology Discovers and develops antibody-based therapeutic drugs | Health Technology |
University of Hannover
 University of Hannover Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Duisburg-Essen
University of Duisburg-Essen Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Molecular Partners AG
 Molecular Partners AG BiotechnologyHealth Technology Engages in discovery, development and commercialization of biopharmaceutical products | Health Technology |
Merck Serono Ltd.
Merck Serono Ltd. Miscellaneous Commercial ServicesCommercial Services Provides research and development services and manufactures medicinal drugs | Commercial Services |
Lilly Oncology
Lilly Oncology Hospital/Nursing ManagementHealth Services Provides cancer treatment services | Health Services |
